Markets:

Overview

News

Currencies

International

Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

4.360 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

69 Biggest Movers From Friday ↗

June 06, 2022

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...

Via Benzinga

40 Stocks Moving In Friday's Mid-Day Session ↗

June 03, 2022

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.

Via Benzinga

4 Analysts Have This to Say About Iovance Biotherapeutics ↗

May 24, 2022

Within the last quarter, Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings:

Via Benzinga

Insiders Buy Around $10M Of 3 Stocks ↗

June 03, 2022

Although the Dow Jones jumped more than 400 points on Thursday, there were a few notable insider trades.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 02, 2022

During the Thursday's session, 100 stocks hit new 52-week lows.

Via Benzinga

Iovance Receives FDA Allowance For IOV-4001 Study In Two Advanced Cancers ↗

March 16, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

June 01, 2022

On Wednesday, 73 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

May 31, 2022

On Tuesday, 36 companies achieved new lows for the year.

Via Benzinga

70 Biggest Movers From Friday ↗

May 31, 2022

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for...

Via Benzinga

Mid-Afternoon Market Update: Dow Gains 500 Points; Red Robin Gourmet Burgers Shares Spike Higher ↗

May 27, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 500 points on Friday.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

May 27, 2022

During Friday's session, 59 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 27, 2022

Gainers

Via Benzinga

Gas Price Predictions: How Much Will Gas Cost Over Memorial Day Weekend? ↗

May 27, 2022

Anyone planning to travel over the Memorial Day Weekend is going to want to check out the latest gas price predictions.

Via InvestorPlace

Why Is Iovance Therapeutics (IOVA) Stock Down 45% Today? ↗

May 27, 2022

Iovance Therapeutics (IOVA) stock is falling hard on Friday following the release of clinical trial data for its melanoma treatment.

Via InvestorPlace

Mid-Morning Market Update: Markets Open Higher; US Goods Trade Deficit Narrows In April ↗

May 27, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 27, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 27, 2022

We're starting the final day of trading for the week with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

20 Stocks Moving in Friday's Pre-Market Session ↗

May 27, 2022

Gainers Adicet Bio, Inc. (NASDAQ: ACET) rose 16% to $11.90 in pre-market trading after reporting positive clinical update from ADI-001 Phase 1 Trial in relapsed/refractory Non-Hodgkin’s Lymphoma.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 26, 2022

Gainers

Via Benzinga

Iovance Biotherapeutics Just Flashed A Bullish Sign Despite Melanoma Drug Delay ↗

April 07, 2022

This biotech stock is mounting a two-day recovery and is well above its 50-day line.

Via Investor's Business Daily

The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy ↗

April 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Iovance Outlines Frontline Melanoma Strategy For Lifileucel / Pembrolizumab Combo Therapy ↗

April 06, 2022

The

Via Benzinga

All The Stocks That Moved Wednesday From CNBC's 'Fast Money: Halftime Report' ↗

March 23, 2022

CNBC's "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often move the stocks mentioned....

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study ↗

March 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 15, 2022

Gainers

Via Benzinga

Recap: Iovance Biotherapeutics Q4 Earnings ↗

February 24, 2022

Iovance Biotherapeutics (NASDAQ:IOVA) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

Iovance's Lifileucel Combo Shows Encouraging Response Rates In Advanced Cancers ↗

November 15, 2021

Iovance Biotherapeutics Inc (NASDAQ: IOVA) has announced data for lifileucel in combination with Merck Co Inc's (NYSE: MRK) Keytruda (pembrolizumab)...

Via Benzinga

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

70 Biggest Movers From Friday ↗

November 15, 2021

Gainers Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4...

Via Benzinga

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.